Please use this identifier to cite or link to this item: http://hdl.handle.net/10637/10799

May Measurement Month 2017 : an analysis of blood pressure screening in Spain-Europe


Thumbnail

See/Open:
 May_Molinero_EHJS_2019.pdf
180,18 kB
Adobe PDF
Title: May Measurement Month 2017 : an analysis of blood pressure screening in Spain-Europe
Authors : Molinero Crespo, Ana
Ruilope Urioste, Luis Miguel
Tous Trepat, Salvador
Fornós Pérez, José Antonio
Mera Gallego, Inés
Andrés Rodríguez, Nicanor Floro
Iracheta Todó, Montserrat
Xia, Xin
Beaney, Thomas
Poulter, Neil R.
Rodilla Sala, Enrique
Martínez García, Fernando
Gijón Conde, Teresa
Keywords: Hypertension - Mensuration - Spain.Hipertensión - Medición - España.
Publisher: European Society of Cardiology ; Oxford University Press.
Citation: Molinero, A., Ruilope, LM., Tous, S., Fornos, JA., Mera, I., Andrés, NF. et al. (2019). May Measurement Month 2017 : an analysis of blood pressure screening in Spain-Europe. European Heart Journal Supplements, vol. 21, Supl. D1 (apr.), pp. D107-D110. DOI: https://doi.org/10.1093/eurheartj/suz070
Abstract: May Measurement Month 2017 is a global initiative aimed at raising awareness of high blood pressure (BP) and to act as a temporary solution to the lack of screening programs worldwide, in which Spain participated actively. The primary objective was to raise awareness and increase control of BP in Spain. An opportunistic crosssectional survey of volunteers aged 18 was set up in May 2017. Following the design of the International Society of Hypertension, data were collected from the 17 autonomous communities in which Spain is divided, mainly in community pharmacies, primary care centres and some hypertension (HT) units, and cardiovascular departments in hospitals. No additional training of volunteers was necessary. A total of 3849 individuals were screened. After multiple imputation, our data showed that 1923 (50.0%) had HT. In those not receiving antihypertensive medication, 17.5% were hypertensives, in individuals receiving antihypertensive medication, 33.9% had uncontrolled BP. May Measurement Month 2017 was the largest BP screening campaign undertaken in Spain. In total, 17.5% of people with HT did not receive medication. One-third of hypertensive participants receiving treatment did not have their BP controlled. These results confirm that an opportunistic screening can identify a significant number of subjects with and untreated and inadequately treated BP.
Description: Este artículo se encuentra disponible en la siguiente URL: https://academic.oup.com/eurheartjsupp/article/21/Supplement_D/D107/5476839
URI: http://hdl.handle.net/10637/10799
Rights : http://creativecommons.org/licenses/by-nc/4.0/deed.es
ISSN: 1520-765X.
1554-2815 (Electrónico).
Issue Date: 24-Apr-2019
Center : Universidad Cardenal Herrera-CEU
Appears in Collections:Dpto. Medicina y Cirugía





Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.